<DOC>
	<DOCNO>NCT00044928</DOCNO>
	<brief_summary>A Phase IV , multicenter study hospitalize patient complicate intra-abdominal infection .</brief_summary>
	<brief_title>Study Evaluating Zosyn Hospitalized Patients With Intra-abdominal Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Intraabdominal Infections</mesh_term>
	<mesh_term>Tazobactam</mesh_term>
	<mesh_term>Piperacillin</mesh_term>
	<mesh_term>Piperacillin , tazobactam drug combination</mesh_term>
	<mesh_term>Penicillanic Acid</mesh_term>
	<criteria>Inclusion Criteria Written inform consent obtain prior enrollment study . If patient unable give consent , may obtain next ofkin legal representative accordance local law regulation Hospitalized , ≥18 year age Male nonpregnant , nonlactating female postmenopausal , surgically sterilize use birth control pill , contraceptive implant injection ( ex : NORPLANT® ; DEPOPROVERA® ) , intrauterine device , barrier method spermicide , abstinence . ( Effective contraception place least two month prior study entry must continue least 30 day treatment discontinuation ) Exclusion Criteria Patients underlying immunodeficiency disease patient require chronic treatment know immunosuppressant medication include &gt; 5mg/day prednisone Active treat leukemia , systemic malignancy require treatment chemotherapy , immunotherapy , radiation therapy , antineoplastic therapy within past year anticipate begin prior TestofCure visit ; know suspected malignancy abdomen Concurrent hemodialysis , peritoneal dialysis patient indwell peritoneal catheter shunt , plasmapheresis hemoperfusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Abdominal Infections</keyword>
</DOC>